Cancer Vaccine Institute News

We're excited to see the findings from our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD...

Dr. Nora Disis (CVI Director) was featured in a New York Times article this week. Dr. Disis shares the promise of our STEMVAC vaccine for...

The Cancer Vaccine Institute will hold a series of virtual seminars during June and July 2022. The five-part seminar series is an...

We’re delighted to announce that the Seattle Chapter of Association for Women in Science (AWIS) has announced that Dr. Nora Disis, CVI...

In 2021, our Cancer Vaccine Institute team worked relentlessly toward our efforts to ignite the immune system to end cancer. To learn...